Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Celcuity Inc. Common Stock
Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
IPO Date: September 20, 2017
Sector: Healthcare
Industry: Medical Diagnostics & Research
Market Cap: $521.8M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.41 | 2.95%
Avg Daily Range (30 D): $0.30 | 2.36%
Avg Daily Range (90 D): $0.28 | 2.58%
Institutional Daily Volume
Avg Daily Volume: .07M
Avg Daily Volume (30 D): .14M
Avg Daily Volume (90 D): .17M
Trade Size
Avg Trade Size (Sh.): 75
Avg Trade Size (Sh.) (30 D): 51
Avg Trade Size (Sh.) (90 D): 55
Institutional Trades
Total Inst.Trades: 272
Avg Inst. Trade: $2.18M
Avg Inst. Trade (30 D): $1.14M
Avg Inst. Trade (90 D): $1.28M
Avg Inst. Trade Volume: .14M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.34M
Avg Closing Trade (30 D): $1.22M
Avg Closing Trade (90 D): $1.68M
Avg Closing Volume: 156.69K
   
News
Jul 8, 2025 @ 2:25 PM
Amid NCI Budget Fears, Emerging Oncology Stocks Ga...
Source: Prnewswire
Feb 27, 2025 @ 3:04 PM
Oncology Breakthroughs: How Cancer Research Is Adv...
Source: Prnewswire
Jun 3, 2024 @ 8:01 PM
Celcuity To Participate in Jefferies Global Health...
Source: Celcuity Inc.
May 30, 2024 @ 11:36 AM
Celcuity Announces Pricing of Underwritten Common ...
Source: Celcuity Inc.
May 30, 2024 @ 11:00 AM
Celcuity Inc. Announces Plan to Initiate a Phase 3...
Source: Celcuity Inc.
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-3.05 $-.86 $-.87
Diluted EPS $-3.05 $-.86 $-.87
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -127.16M $ -37M $ -36.65M
Operating Income / Loss $ -126.91M $ -36.13M $ -36.43M
Cost of Revenue $ $ $
Net Cash Flow $ -14.74M $ -6.04M $ 9.91M
PE Ratio